#None #Toronto #Pharmacovigilance #Biosimilars #Xtalks

Stay Informed: Upcoming Webinar on Biosimilars Safety

In today’s rapidly evolving pharmaceutical landscape, the introduction of biosimilars offers new opportunities for patient care and cost-effective treatments. As we witness a growth in the biosimilars market, understanding the complexities of their safety management is crucial for professionals in the healthcare industry. To address this need, Xtalks is hosting a comprehensive webinar titled "Safety for Biosimilars: Strategic Pharmacovigilance Solutions," scheduled for Friday, October 17, 2025, at 10 AM EDT (4 PM CEST).

What to Expect

This webinar is designed to provide participants with insights into the intricate regulatory framework governing biosimilars and their approval processes. During this session, attendees will gain valuable knowledge on how to develop scalable pharmacovigilance strategies specifically tailored for biosimilars throughout their product lifecycle. The discussion will also illuminate how advanced technologies and automation can enhance safety monitoring and streamline the surveillance processes affecting these complex biologics.

Key Learning Objectives:

1. Pharmacovigilance Strategy Development: Understand how to craft pharmacovigilance strategies that address the unique attributes of biosimilars, ensuring a robust monitoring system is in place.
2. Technological Integration: Explore the role of advanced technologies in improving safety surveillance and the efficiency of monitoring systems - critical for accommodating the large, complex molecules that biosimilars represent.
3. Regulatory Insights: Stay abreast of the constantly changing regulations that pertain to biosimilar approval and pharmacovigilance, vital for any stakeholder in the pharmaceutical sector.
4. Educational Frameworks: Discover effective methods for building educational initiatives that foster confidence among healthcare providers and patients when it comes to adopting biosimilars.

Expert Speakers

The webinar will feature industry experts:

• - Ivana Lisec, Vice President of Project Management/Business Unit Leader, EU QPPV at PrimeVigilance
• - Sara Lipovac, Senior Case Processing Manager

Their expertise will provide valuable perspectives on effectively navigating the challenges posed by biosimilar safety management.

Why You Should Attend

Whether you are involved in pharmaceutical development, regulation, or the clinical practice, this webinar will enhance your understanding of biosimilars and their management. Participants will leave equipped with practical solutions and a framework to tackle pressing challenges in biosimilar safety and efficacy. Additionally, engaging with thought leaders in the field will provide attendees with a broader network and access to collective knowledge.

Registration Details

This free event is an excellent opportunity for professionals in biopharmaceuticals, institutional research, and clinical practice to enhance their skills and knowledge. To register for the event, visit Xtalks where more detailed information is available.

Don’t miss out on this chance to deepen your understanding of biosimilars and ensure that your pharmacovigilance strategies are up to date and effective. Register today!

• ---

By participating in this webinar, you will engage with current issues surrounding biosimilars and help pave the way for safer healthcare outcomes worldwide. Together, let’s make strides toward refining biosimilar safety monitoring and fostering informed adoption within the medical community.